<DOC>
	<DOC>NCT00801788</DOC>
	<brief_summary>The purpose of the study is to evaluate the pharmacokinetic profile of different Egalet® oxycodone formulations and compare to a marketed oxycodone product.</brief_summary>
	<brief_title>Single Dose Pharmacokinetics of Egalet® Oxycodone</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Main inclusion criteria: ≥18 years and ≤55 years Nonsmoker BMI ≥18.0 and ≤30.0 Main exclusion criteria: Any clinically significant abnormality or abnormal laboratory test results found during medical screening History of allergic reactions to opioids or other related drugs History of significant alcohol abuse or drug abuse Use of any drugs known to inhibit hepatic drug metabolism Pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>